SCHRÖDINGER, INC.

Insiders Schrödinger, Inc.

Equities

SDGR

US80810D1037

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
20.71 ^USD	+3.03%		+7.08%	-42.15%

Jul. 02	Leerink Initiates Schrodinger at Outperform Rating With $29 Price Target	MT
May. 13	Ajax Therapeutics, Inc. announced that it has received $94.99996 million in funding from a group of investors	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Insider Sell: Schrodinger	23-08-10	MT
Insider Sell: Schrodinger	23-05-24	MT
Insider Sell: Schrodinger	23-05-23	MT
Insider Sell: Schrodinger	23-02-03	MT
Insider Sell: Schrodinger	23-01-05	MT
Schrodinger Names Geoffrey Porges Chief Financial Officer	22-08-18	MT
Schrödinger, Inc. Announces Executive Changes	22-08-18	CI
Schrödinger, Inc. Appoints of Arun Oberoi to Board of Directors	22-05-19	CI
Schrodinger Finance Chief Joel Lebowitz to Retire	21-12-21	MT
Insider Sell: Schrodinger	21-12-14	MT
Insider Sell: Schrodinger	21-09-14	MT
Insider Sell: Schrodinger	21-09-03	MT
Schrödinger, Inc. Announces Board Changes	20-05-04	CI
Schrödinger, Llc Appoints Drug Discovery Veteran Nancy Thornberry to Board of Directors	19-09-24	CI
Schrödinger Appoints Gary Sender to its Board of Directors	19-08-05	CI
Schrödinger Appoints Veteran Biotech Industry Leader Dr. Rosana Kapeller to Board of Directors	19-01-23	CI
Schrödinger and TB Alliance Announce Collaboration to Accelerate Tuberculosis Drug Discovery	18-12-11	CI
Schrodinger Names Joel Lebowitz as CFO	18-11-27	CI
Schrödinger Appoints Veteran Pharmaceutical Executive Joel Lebowitz as Chief Financial Officer	18-11-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer